Rani Therapeutics Holdings, Inc 10-Q for FY2023 Q2
Rani Therapeutics Holdings, Inc. (RANI)
10-Q
2023-08-11
For: 2023-06-30
View Original
Added on
April 06, 2026
About this 10-Q
Rani Therapeutics Holdings, Inc filed this 10-Q on August 11, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $9.3M
- compared with a net loss of $7.62M a year earlier
- Diluted EPS
- $0.37
- up 19.4% from $0.31 a year earlier